Digital sexually transmitted infection and HIV services across prevention and care continuums: evidence and practical resources.


Journal

Sexual health
ISSN: 1449-8987
Titre abrégé: Sex Health
Pays: Australia
ID NLM: 101242667

Informations de publication

Date de publication:
08 2022
Historique:
received: 08 02 2022
accepted: 05 05 2022
pubmed: 16 6 2022
medline: 1 9 2022
entrez: 15 6 2022
Statut: ppublish

Résumé

Increased demand for sexual health services (including prevention and treatment) have spurred the development of digital STI/HIV services. Earlier advances in testing technologies opened the door for self-testing and self-sampling approaches, in line with broader self-care strategies. Advances in HIV management mean that many people are living well with HIV and no longer need intensive in-person monitoring, whereas those at-risk of HIV are recommended to have regular asymptomatic STI screening and pre-exposure prophylaxis. This narrative review examines the evidence and implications of digital STI/HIV services, focused on promoting testing, facilitating testing, clinical management and referrals, partner services, and prevention. We have used a prevention and care continuum to structure the review to increase utility to policy as well as practice. Digital STI/HIV services can be interwoven into existing clinical pathways to enhance face-to-face services or standalone digital STI/HIV services. A growing evidence base, including randomised controlled trials and observational studies, should help inform strategies for designing effective digital STI/HIV services. However, most studies to date have focused on high-income countries and people with smartphones, despite a substantial burden of STI/HIV in low- and middle-income countries. There are also important differences between digital STI and HIV services that require careful consideration. We discuss digital STI/HIV service evidence and implications to inform research and programs in this exciting field.

Identifiants

pubmed: 35705515
pii: SH22023
doi: 10.1071/SH22023
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

278-285

Subventions

Organisme : NICHD NIH HHS
ID : UH3 HD096929
Pays : United States
Organisme : NIAID NIH HHS
ID : K24 AI143471
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI158826
Pays : United States

Auteurs

Joseph D Tucker (JD)

Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; and Clinical Research Department, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Jane Hocking (J)

Faculty of Medicine, Dentistry, and Health Sciences, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Vic., Australia.

David Oladele (D)

Clinical Research Department, Nigerian Institute of Medical Research, Lagos, Nigeria.

Claudia Estcourt (C)

School of Health & Life Sciences, Glasgow Caledonian University, Glasgow, UK; and Sandyford Sexual Health Services, NHS Greater Glasgow & Clyde, Glasgow, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH